Evidence map›Paper›PMID 29153923›Full record

ArticleMolecular metabolism2018

Macrophages sensing oxidized DAMPs reprogram their metabolism to support redox homeostasis and inflammation through a TLR2-Syk-ceramide dependent mechanism.

Vlad Serbulea, Clint M Upchurch, Katelyn W Ahern, Gael Bories, Paxton Voigt, Dory E DeWeese, Akshaya K Meher, Thurl E Harris, Norbert Leitinger

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. TLR2 reprograms glucose metabolism in CD4Clinical rheumatology · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Vlad SerbuleaDepartment of Pharmacology, University of Virginia, Charlottesville, VA 22903, USA.
Clint M UpchurchDepartment of Pharmacology, University of Virginia, Charlottesville, VA 22903, USA.
Katelyn W AhernDepartment of Pharmacology, University of Virginia, Charlottesville, VA 22903, USA; Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22903, USA.
Gael BoriesDepartment of Pharmacology, University of Virginia, Charlottesville, VA 22903, USA.
Paxton VoigtDepartment of Pharmacology, University of Virginia, Charlottesville, VA 22903, USA.
Dory E DeWeeseDepartment of Pharmacology, University of Virginia, Charlottesville, VA 22903, USA.
Akshaya K MeherDepartment of Pharmacology, University of Virginia, Charlottesville, VA 22903, USA.
Thurl E HarrisDepartment of Pharmacology, University of Virginia, Charlottesville, VA 22903, USA; Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22903, USA.
Norbert LeitingerDepartment of Pharmacology, University of Virginia, Charlottesville, VA 22903, USA; Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22903, USA. Electronic address: nl2q@virginia.edu.
University of Virginia · US

Funding

Role of Pannexins in Vascular Smooth Muscle CellsP01HL120840 · NHLBI · UNIVERSITY OF VIRGINIA · PI BAYLISS, DOUGLAS A. · 2014 to 2023
$24.0M
BASIC CARDIOVASCULAR RESEARCH TRAINING GRANTT32HL007284 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Brant E Isakson, Gary K Owens · 1985 to 2026
$19.6M
TRAINING IN THE PHARMACOLOGICAL SCIENCEST32GM007055 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LYNCH, KEVIN R. · 1985 to 2022
$7.2M
Role of Oxidized neutral lipids in adipocyte functionR01DK101946 · NIDDK · UNIVERSITY OF VIRGINIA · PI HARRIS, THURL E. · 2014 to 2018
$1.7M
Role of Dab2 in Fatty Liver DiseaseR01DK096076 · NIDDK · UNIVERSITY OF VIRGINIA · PI LEITINGER, NORBERT · 2013 to 2016
$1.4M
The Role of Oxidized Phospholipids in Macrophage Bioenergetics and InflammationF31DK108553 · NIDDK · UNIVERSITY OF VIRGINIA · PI SERBULEA, VLAD · 2016 to 2017
$60k
NHLBI NIH HHS P01 HL120840NHLBI NIH HHS T32 HL007284NIDDK NIH HHS F31 DK108553NIDDK NIH HHS R01 DK096076NIDDK NIH HHS R01 DK101946NIGMS NIH HHS T32 GM007055
6 · The paper itself

Abstract

objectiveMacrophages control tissue homeostasis and inflammation by sensing and responding to environmental cues. However, the metabolic adaptation of macrophages to oxidative tissue damage and its translation into inflammatory mechanisms remains enigmatic.

methodsHere we identify the critical regulatory pathways that are induced by endogenous oxidation-derived DAMPs (oxidized phospholipids, OxPL) in vitro, leading to formation of a unique redox-regulatory metabolic phenotype (Mox), which is strikingly different from conventional classical or alternative macrophage activation.

resultsUnexpectedly, metabolomic analyses demonstrated that Mox heavily rely on glucose metabolism and the pentose phosphate pathway (PPP) to support GSH production and Nrf2-dependent antioxidant gene expression. While the metabolic adaptation of macrophages to OxPL involved transient suppression of aerobic glycolysis, it also led to upregulation of inflammatory gene expression. In contrast to classically activated (M1) macrophages, Hif1α mediated expression of OxPL-induced Glut1 and VEGF but was dispensable for Il1β expression. Mechanistically, we show that OxPL suppress mitochondrial respiration via TLR2-dependent ceramide production, redirecting TCA metabolites to GSH synthesis. Finally, we identify spleen tyrosine kinase (Syk) as a critical downstream signaling mediator that translates OxPL-induced effects into ceramide production and inflammatory gene regulation.

conclusionsTogether, these data demonstrate the metabolic and bioenergetic requirements that enable macrophages to translate tissue oxidation status into either antioxidant or inflammatory responses via sensing OxPL. Targeting dysregulated redox homeostasis in macrophages could therefore lead to novel therapies to treat chronic inflammation.

Indexed as

HomeostasisOxidative StressAnimalsCells, CulturedCeramidesGlucoseGlucose Transporter Type 1GlutathioneHypoxia-Inducible Factor 1, alpha SubunitInterleukin-1betaMacrophagesMiceMice, Inbred C57BLNF-E2-Related Factor 2Pentose Phosphate PathwaySignal TransductionCeramidesGlucoseGlucose Transporter Type 1GlutathioneHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitInterleukin-1betaNF-E2-Related Factor 2Slc2a1 protein, mouseSyk KinaseSyk protein, mouseTlr2 protein, mouseToll-Like Receptor 2Vascular Endothelial Growth Factor ABioenergeticsCellular metabolismCeramidesInflammationMacrophagesOxidized phospholipidsRedox homeostasisSpleen tyrosine kinase

Identifiers

PMID29153923
PMCPMC5784323
OpenAlexW2767748723

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.